Low density Lipoprotein cholesterol target: Changing goal posts

Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bantwal, Ganapathi, George, Belinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603034/
https://www.ncbi.nlm.nih.gov/pubmed/23565386
http://dx.doi.org/10.4103/2230-8210.104047
Descripción
Sumario:Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary prevention and secondary prevention. In this article, we review the evolving trend of aggressive LDL cholesterol lowering strategies.

Ejemplares similares